Nuo Therapeutics, Inc. (AURX)

R&D Expense Growth

0.00%

Fiscal year · Period ending:

AURX logo

AURX R&D Expense Growth

Latest reported0.00%
AURX FY R&D Growth (YoY) (0.00% → 0.00%)
High-resolution chart · PNG

AURX r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuo Therapeutics, Inc. R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
0%
0%
0%
0%
0%
-100%
-68.5548%
-56.6226%
-9.2338%
-42.6276%
-2.7724%
-30.9303%
12.165%
3,350.3393%
-76.3859%
82.7039%
56.122%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.